Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone
Authors:
- 1 November 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (11) , 1659-1664
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- 8 Chemotherapy and radiotherapy of malignant hepatic tumoursBailliere's Clinical Gastroenterology, 1987
- Active uptake of testosterone by androgen receptors of hepatocellular carcinoma in humansCancer, 1986
- Androgen and estrogen receptors in hepatocellular carcinoma and in the surrounding noncancerous liver tissueHepatology, 1986
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levelsJournal of Hepatology, 1986
- Characterisation of high affinity binding sites of androgens in primary hepatocellular carcinomaClinica Chimica Acta, 1985
- Androgen receptors in hepatocellular carcinoma and surrounding parenchymaGastroenterology, 1985
- Mitozantrone as single agent therapy in hepatocellular carcinomaJournal of Hepatology, 1985
- Primary liver cancer. An eastern cooperative oncology group trialCancer, 1984
- Sex steroid receptor proteins in foetal, adult and malignant human liver tissueBritish Journal of Cancer, 1983
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978